The FDA Centennial and the Drug Information Association Michael R. Hamrell From the Editor-in-Chief 30 December 2006 Pages: xix - xx
Marker Profiling of Botanicals Used for Hepatoprotection in Indian System of Medicine Pulok K. MukherjeeAtul WahileB. P. Saha Research 30 December 2006 Pages: 131 - 139
Factors Influencing Physician Recommendation for Imatinib Mesylate in Chronic Phase Chronic Myeloid Leukemia Shrividya IyerWilliam R. Doucette Research 30 December 2006 Pages: 141 - 153
International Workshop on Qualification and Control of Impurities Leon A. G. J. M. Van AertsPeter KasperAnthony Cartwright Special Reports 30 December 2006 Pages: 155 - 163
Auditing Safety-Related Processes and Procedures: Lessons Learned for Global Compliance and Quality Stephen A. Goldman Special Report 30 December 2006 Pages: 165 - 175
Apples and Oranges: Comparing Computer Systems Audits Jacques Mourrain Technology 30 December 2006 Pages: 177 - 183
Safer, Better, More Appropriate: Clinical Trial Design for Pediatric Drug Labels Susan K. McCuneLisa L. MathisW. Rodriguez Clinical Trials 30 December 2006 Pages: 185 - 195
Reviewing Statistical Analysis Plans—A Guide for Medical Writers Deborah McPhailIsy GoodwinKerry Gordon Medical Writing 30 December 2006 Pages: 197 - 202
A Note on Comparing Two Binomial Proportions in Confirmatory Noninferiority Trials Zhengqing LiChristy Chuang-Stein Statistics 30 December 2006 Pages: 203 - 208
Re-treatment Studies: Design and Analysis Cornelia Dunger-BaldaufAmy RacineGary Koch Statistics 30 December 2006 Pages: 209 - 217
A Note on Hypothesis Test in Binary Data under the Single-Consent Randomized Design Kung-Jong Lui Statistics 30 December 2006 Pages: 219 - 227
Statistical Analysis of in Vivo Anticancer Experiments: Tumor Growth Inhibition Ludwig A. Hothorn Statistics 30 December 2006 Pages: 229 - 238
